[HTML][HTML] Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: A systematic review of the literature …
R Squeri, C Genovese - Journal of Preventive Medicine and …, 2020 - ncbi.nlm.nih.gov
Materials and methods We prepared a review according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …
[HTML][HTML] Immunogenicity and antibody persistence of diphteriatetanus-acellular pertussis vaccination in adolescents and adults: a systematic review of the literature …
R Squeri, C Genovese - J Prev Med Hyg, 2021 - ncbi.nlm.nih.gov
Materials and methods We prepared a review according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …
Duration of pertussis immunity after DTaP immunization: a meta-analysis
A McGirr, DN Fisman - Pediatrics, 2015 - publications.aap.org
BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …
introduction of acellular vaccines, which may have decreased the durability of immune …
[HTML][HTML] Systematic review of immunogenicity and duration of immunity of currently licensed pertussis wP vaccines in children
AM Bagattini, MM Quarti… - Gates Open …, 2022 - gatesopenresearch.org
Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …
children includes a 3-dose primary schedule, and at least one booster dose. When …
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a …
P Pitisuttithum, K Chokephaibulkit… - The Lancet Infectious …, 2018 - thelancet.com
Background The immunogenicity of acellular pertussis vaccines and persistence of immunity
after vaccination might be improved by using genetically inactivated pertussis toxin (PTgen) …
after vaccination might be improved by using genetically inactivated pertussis toxin (PTgen) …
Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …
R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …
of booster doses in older children and adults. This can be conveniently accomplished by …
[HTML][HTML] The association between vaccine hesitancy and pertussis: a systematic review and meta-analysis
Y Wang, N Shi, Q Wang, L Yang, T Cui, H Jin - Italian Journal of Pediatrics, 2023 - Springer
Background Robust routine immunization schedules for pertussis-containing vaccines have
been applied for years, but pertussis outbreaks remain a worldwide problem. This study …
been applied for years, but pertussis outbreaks remain a worldwide problem. This study …
A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers
BA Randi, ONE Sejas, KT Miyaji, V Infante, AN Lara… - Vaccine, 2019 - Elsevier
During the last decades pertussis incidence raised globally. Several vaccination strategies
targeting adults to reduce pertussis among young infants have been proposed, including …
targeting adults to reduce pertussis among young infants have been proposed, including …
[PDF][PDF] Gates Open Research
AM Bagattini, MM Quarti, MS Martinez-Silveira… - 2022 - researchgate.net
Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …
children includes a 3-dose primary schedule, and at least one booster dose. When …
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age
GS Marshall, V Pool, DP Greenberg… - Clinical and Vaccine …, 2014 - Am Soc Microbiol
Boosting immunity to tetanus, diphtheria, and pertussis through the use of Tdap vaccines is
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …